Cetirizine Hydrochloride Syrup: Latest News on Cetirizine Hydrochloride Syrup, Cetirizine Hydrochloride Syrup Updates, Cetirizine Hydrochloride Syrup Videos, Photos, Wiki, Topic

Share >

Share on Tumblr

Cetirizine Hydrochloride Syrup

News »
latest by relevance

Wockhardt gets US FDA approval for ulcers syrup; stk up

Feb 27, 2009 at 10:41 | Source: Moneycontrol.com

Wockhardt had touched an intraday high of Rs 82.90 and an intraday low of Rs 81.35. At 10:41 am, the share was quoting at Rs 82.00, up Rs 0.90, or 1.11% on the NSE. The company has got US FDA approval for ulcers and hyperacidity syrup Hydrochloride, reports CNBC-TV18. It was trading with volumes of 35,935 shares.

Ranbaxy gets approval for Cetirizine Hydrochloride

Apr 25, 2008 at 18:28

Ranbaxy receives final US FDA approval to manufacture and market Cetirizine Hydrochloride Oral Solution

Wockhardt launches allergy drug in US

Jan 02, 2008 at 09:02 | Source: Business Line

Wockhardt Ltd has launched Cetirizine tablets in the US, after having received the regulatory approval to market different strengths of anti-allergy medicine Cetirizine Hydrochloride, reports Business Line.

Ranbaxy gets approval for Cetirizine Hydrochloride tabs

Dec 31, 2007 at 15:15 | Source:

Ranbaxy receives final approval to manufacture and market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg

Ranbaxy gets approval to mfg Cetirizine Hydrochloride Syrup

Nov 05, 2006 at 13:00

Ranbaxy receives tentative USFDA approval to manufacture and market Cetirizine Hydrochloride Syrup

Photos »

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window

Explore Moneycontrol

STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

MUTUAL FUNDS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.